Prevalence of peripheral arterial disease and associated risk factors in American Indians: The Strong Heart Study

American Journal of Epidemiology

Volumn 149, Issue 4, 1999, Pages 330-338

  Fabsitz, R R ^a,g   Sidawy, A N ^b   Go, O ^c   Lee, E T ^c   Welty, T K ^d   Devereux, R B ^e   Howard, B V ^f  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^d Aberdeen Area Tribal Chairmen's H   (United States)

^e WEILL CORNELL MEDICAL CENTER   (United States)

^f Medlantic Research Institute   (United States)

^g II Rockledge Center   (United States)

Author keywords

Albuminuria; Arterial occlusive diseases; Atherosclerosis; Blood pressure; Diabetes mellitus; Fibrinogen; Indians, North American; Smoking

Indexed keywords

ALBUMIN; ALCOHOL; CHOLESTEROL; FIBRINOGEN; GLUCOSE; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN;

CARDIOVASCULAR DISEASE; DISEASE PREVALENCE; INDIGENOUS POPULATION; RISK FACTOR;

ADULT; AGED; ALCOHOL CONSUMPTION; AMERICAN INDIAN; ARTICLE; CIGARETTE SMOKING; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINORITY GROUP; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; PROTEINURIA; RISK FACTOR;

NORTH AMERICA;

EID: 0033557396     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009817     Document Type: Article

References (44)

1. Sidawy AN, Schweitzer EJ, Neville RF, et al. Race as a risk factor in the severity of infragenicular occlusive disease: study of an urban hospital patient population. J Vasc Surg 1990; 11:536-43.
2. Orchard TJ, Strandness DE Jr. Assessment of peripheral vascular disease in diabetes. Circulation 1993;88:819-28.
3. Criqui MH, Fronek A, Klauber MR, et al. The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population. Circulation 1985;71:516-22.
4. Janka HU, Standl E, Mehnert H. Peripheral vascular disease in diabetes mellitus and its relation to cardiovascular risk factors: screening with the Doppler ultrasonic technique. Diabetes Care 1980;3:207-13.
5. Fowkes FG. The measurement of atherosclerotic peripheral arterial disease in epidemiological surveys. Int J Epidemiol 1988;17:248-54.
6. Fowkes FG, ed. Epidemiology of peripheral vascular disease. London, England: Springer-Verlag, 1991.
7. Hiatt WR, Marshall JA, Baxter J, et al. Diagnostic methods for peripheral arterial disease in the San Luis Valley Diabetes Study. J Clin Epidemiol 1990;43:597-606.
8. De Backer G, Kornitzer M, Sobolski J, et al. Intermittent claudication - epidemiology and natural history. Acta Cardiol 1979;34:115-24.
9. Beach KW, Strandness DE Jr. Arteriosclerosis obliterans and associated risk factors in insulin-dependent and non-insulin-dependent diabetes. Diabetes 1980;29:882-8.
10. Kornitzer M, Dramaix M, De Backer G, et al. Epidemiology of peripheral vascular disease by the Doppler ultrasonic technique. In: Reinis Z, Pokorny J, Linhart J, et al, eds. Adaptability of vascular wall. Berlin, Federal Republic of Germany: Springer-Verlag, 1978:291-3.
11. Schroll M, Munck O. Estimation of peripheral arteriosclerotic disease by ankle blood pressure measurements in a population study of 60-year-old men and women. J Chronic Dis 1981; 34:261-9.
12. Criqui MH, Fronek A, Barrett-Connor E, et al. The prevalence of peripheral arterial disease in a defined population. Circulation 1985;71:510-15.
13. Pomrehn P, Duncan B, Weissfeld L, et al. The association of dyslipoproteinemia with symptoms and signs of peripheral arterial disease: The Lipid Research Clinics Program Prevalence Study. Circulation 1986;73(suppl 1):I100-7.
14. Gofin R, Kark JD, Friedlander Y, et al. Peripheral vascular disease in a middle-aged population sample: The Jerusalem Lipid Research Clinic Prevalence Study. Isr J Med Sci 1987;23: 157-67.
15. Newman AB, Sutton-Tyrrell K, Rutan GH, et al. Lower extremity arterial disease in elderly subjects with systolic hypertension. J Clin Epidemiol 1991;44:15-20.
16. Stoffers HE, Kaiser V, Knottnerus JA. The prevalence in general practice. In: Fowkes FG, ed. Epidemiology of peripheral vascular disease. New York, NY: Springer-Verlag, 1991: 109-15.
17. Fowkes FG, Housley E, Cawood EH, et al. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991;20:384-92.
18. Vogt MT, McKenna M, Wolfson SK, et al. The relationship between ankle brachial index, other atherosclerotic disease, diabetes, smoking and mortality in older men and women. Atherosclerosis 1993;101:191-202.
19. Newman AB, Siscovick DS, Manolio TA, et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Health Study (CHS) Collaborative Research Group. Circulation 1993;88:837-45.
20. Vogt MT, Wolfson SK, Kuller LH. Segmental arterial disease in the lower extremities: correlates of disease and relationship to mortality. J Clin Epidemiol 1993;46:1267-76.
21. Kannel WB, Skinner JJ Jr, Schwartz MJ, et al. Intermittent claudication: incidence in the Framingham Study. Circulation 1970;41:875-83.
22. Kannel WB, McGee DL. Update on some epidemiologic features of intermittent claudication: The Framingham Study. J Am Geriatr Soc 1985;33:13-18.
23. Smith GD, Shipley MJ, Rose G. Intermittent claudication, heart disease risk factors, and mortality: The Whitehall Study. Circulation 1990;82:1925-31.
24. Kreines K, Johnson E, Albrink M, et al. The course of peripheral vascular disease in non-insulin-dependent diabetes. Diabetes Care 1995;8:235-43.
25. Tell GS, Fried LP, Hermanson B, et al. Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. Ann Epidemiol 1993;3:358-66.
26. Shahar E, Folsom AR, Jackson R. The effect of nonresponse on prevalence estimates for a referent population: insights from a population-based cohort study. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Ann Epidemiol 1996;6:498-506.
27. Lee ET, Welty TK, Fabsitz R, et al. The Strong Heart Study -a study of cardiovascular disease in American Indians: design and methods. Am J Epidemiol 1990;132:1141-55.
28. Welty TK, Lee ET, Yeh J, et al. Cardiovascular disease risk factors among American Indians: The Strong Heart Study. Am J Epidemiol 1995;142:269-87.
29. Howard BV, Lee ET, Cowan LD, et al. Coronary heart disease prevalence and its relation to risk factors in American Indians: The Strong Heart Study. Am J Epidemiol 1995;142: 254-68.
30. Lee ET, Howard BV, Savage PJ, et al. Diabetes and impaired glucose tolerance in three American Indian populations aged 45-74 years: The Strong Heart Study. Diabetes Care 1995; 18:599-610.
31. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, MD: National Heart, Lung, and Blood Institute, 1993. (NIH publication no. 93-1088).
32. Howard BV, Lee ET, Yeh JL, et al. Hypertension in adult American Indians - The Strong Heart Study. Hypertension 1996;28:256-64.
33. Lipid Research Clinics Program. Manual of laboratory operations. Vol 1. Washington, DC: US Department of Health, Education, and Welfare, 1975. (DHEW publication no. 75-628).
34. Morgan C, Lazarow A. Immunoassay of insulin: two antibody system. Plasma insulin levels in normal, subdiabetic and diabetic rats. Diabetes 1963;12:115-26.
35. Little RR, England JD, Wiedmeyer HM, et al. Interlaboratory standardization of glycated hemoglobin determinations. Clin Chem 1986;32:358-60.
36. Vasquez B, Flock EV, Savage PJ, et al. Sustained reduction of proteinuria in type 2 (non-insulin-dependent) diabetes following diet-induced reduction of hyperglycaemia. Diabetologia 1984;26:127-33.
37. Chasson AL, Grady HJ, Stanley MA. Determination of creatinine by means of automatic chemical analysis. Then Gull Regist Med Tech 1960;30:207-12.
38. von Claus A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957;17:237-46.
39. Rose GA, Blackburn H. Cardiovascular survey methods. Geneva, Switzerland: World Health Organization, 1968.
40. Cox DR, Snell EJ. The analysis of binary data. 2nd ed. London, England: Chapman and Hall Ltd, 1989.
41. Zheng Z-J, Barnes RW, Chambless LE, et al. Lower extremity arterial disease by ankle-branchial index in middle-aged black and white men and women: The Atherosclerosis Risk in Communities (ARIC) Study. (Abstract). Circulation 1994; 89:943.
42. Lowe GD, Fowkes FG, Dawes J, et al. Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation 1993;87:1915-20.
43. Fowkes FG, Housley E, Riemersma RA, et al. Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol 1992;135:331-40.
44. Criqui MH, Browner D, Fronek A, et al. Peripheral arterial disease in large vessels is epidemiologically distinct from small vessel disease: an analysis of risk factors. Am J Epidemiol 1989;129:1110-19.